Midwall Fibrosis: Cardiac Magnetic Resonance Imaging in Risk Stratifying Cardiomyopathies
D.P. Ripley1, 2, *, P. Garg3, A. Kotecha1, O.E. Gosling1, 2, N.G. Bellenger1, 2
Identifiers and Pagination:Year: 2015
First Page: 89
Last Page: 90
Publisher ID: TOCMJ-9-89
Article History:Received Date: 22/7/2015
Revision Received Date: 20/8/2015
Acceptance Date: 22/9/2015
Electronic publication date: 30/10/2015
Collection year: 2015
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/ 3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
The United Kingdom’s National Institute for Health and Care Excellence guidance on implantable cardiac defibrillator (ICD) therapy recommend ICD in those with left ventricular dysfunction and a high risk of sudden cardiac death (SCD). SCD accounts for 30% deaths in non-ischaemic dilated cardiomyopathy (DCM), however risk stratifying and predicting SCD in DCM is a major management challenge. We present two cases demonstrating the potential role of cardiac magnetic resonance imaging in risk stratifying DCM.